ABVC — ABVC Biopharma Cashflow Statement
0.000.00%
Last trade - 00:00
- $9.95m
- $11.25m
- $0.15m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -3.93 | -10.6 | -12 | -16.3 | -10.9 |
Depreciation | |||||
Deferred Taxes | |||||
Non-Cash Items | 0.227 | 6.3 | 5.22 | 7.39 | 5.79 |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 0.598 | -0.086 | -1.61 | 0.636 | 0.735 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Taxes Payable | |||||
Change in Other Liabilities | |||||
Net Change in Other Assets & Liabilities | |||||
Cash from Operating Activities | -3.13 | -4.56 | -7.6 | -7.4 | -4.24 |
Capital Expenditures | — | — | -0.018 | -0.12 | -0.021 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | -0.035 | -0.225 | -0.788 | -1.6 | -0.339 |
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -0.035 | -0.225 | -0.806 | -1.72 | -0.36 |
Financing Cash Flow Items | — | — | -0.85 | 0 | — |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 3.09 | 9.57 | 10 | 4.01 | 3.92 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -0.082 | 4.84 | 1.56 | -5.17 | -0.675 |